41132 - Drugs: Prices (Answered)

Keith Vaz
To ask the Secretary of State for Health, what plans he has to bring forward proposals for a change to legislation to further regulate the pricing of everyday drugs to the NHS by pharmaceutical companies.

George Freeman

The Department is already referring cases to the Competition and Market Authority (CMA) and to strengthen our work in this area. We are considering putting measures in place to routinely and systematically monitor significant price increases of generic medicines and take action where appropriate, including the possible referral of suspected excessive pricing to the CMA, while taking into account the potential impact of any such action on the availability of medicines.